# Effects of Supplementation With PUFAs and Antioxidants for Contact Lens Discomfort

> **NCT04163328** · PHASE4 · TERMINATED · sponsor: **University of Alabama at Birmingham** · enrollment: 31 (actual)

## Conditions studied

- Dry Eye
- Contact Lens Complication

## Interventions

- **DRUG:** HydroEye®

## Key facts

- **NCT ID:** NCT04163328
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-09-16
- **Primary completion:** 2024-08-21
- **Final completion:** 2024-08-21
- **Target enrollment:** 31 (ACTUAL)
- **Why stopped:** COVID disruptions to recruitment and study completion, unforeseen staffing and other issues
- **Last updated:** 2025-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04163328

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04163328, "Effects of Supplementation With PUFAs and Antioxidants for Contact Lens Discomfort". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT04163328. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*